It has been a bit of a mixed week for the S&P/ASX 200 (Index: ^AXJO) (ASX: XJO). The benchmark index has had a number of ups and downs and finds itself trading just a touch higher than where it started week-to-date.
But that hasn’t stopped the three shares below from storming to all-time highs. Here’s why:
The AGL Energy Ltd (ASX: AGL) share price stormed to an all-time high of $26.91 during yesterday’s trade. A solid half-year result, a new dividend policy, and rising wholesale electricity prices have all played a part in driving its shares higher. Although I think it is starting to look a little expensive now, I expect that it could climb higher after UBS upgraded its shares this morning to a buy rating with a $29.50 price target.
The National Veterinary Care Ltd (ASX: NVL) share price hit an all-time high of $2.65 on Thursday. Yesterday’s gain means the veterinary service provider’s shares have now climbed a massive 23% in 2017. A solid half-year result in February appears to have impressed many in the market. Especially Washington H. Soul Pattinson and Co. Ltd (ASX: SOL) which has just increased its stake in the company to 7.8%. Despite its shares being at an all-time high, I think National Veterinary Care would still be a great buy and hold investment today.
The Opthea Ltd (ASX: OPT) share price rocketed to a new high of $1.15 yesterday as investors continued to pile into the developer of novel biologic therapies for the treatment of eye diseases. The catalyst for this was the positive results from the Phase 1/2A clinical trial of its novel therapy OPT-302. Whilst there is still a lot of work to be done, the early progress the company has made is certainly very promising. For this reason I think its shares deserve a spot on your watch list.
If you missed out on these gains don't worry. I believe these blue-chip shares could provide investors with outsized returns over the next few years. Do you have them in your portfolio?
For many, blue chip stocks means stability, profitability and regular dividends, often fully franked..
But knowing which blue chips to buy, and when, can often be fraught with danger.
The Motley Fool’s in-house analyst team has poured over thousands of hours worth of proprietary research to bring you the names of "The Motley Fool’s Top 3 Blue Chip Stocks for 2017."
Each one pays a fully franked dividend. Each one has not only grown its profits, but has also grown its dividend. One increased it by a whopping 33%, while another trades on a grossed up (fully franked) dividend yield of almost 7%.
If you’re expecting to see the likes of Commonwealth Bank, Telstra and Wesfarmers shares on this list, you’ll be sorely disappointed. Not only are their dividends growing at a snail’s pace, their profits are under pressure too due to the increasing competitive environment.
The contrast to these “new breed” blue chips couldn’t be greater… especially the very real prospect of significant share price gains, something that’s looking less likely from the usual blue chip suspects.
The names of these Top 3 ASX Blue Chips are included in this specially prepared free report. But you will have to hurry. Depending on demand – and how quickly the share prices of these companies moves – we may be forced to remove this report.
Click here to claim your free report.
Motley Fool contributor James Mickleboro has no position in any stocks mentioned. The Motley Fool Australia owns shares of Washington H. Soul Pattinson and Company Limited. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.